Ignite Creation Date:
2024-05-05 @ 5:14 PM
Last Modification Date:
2024-10-26 @ 9:29 AM
Study NCT ID:
NCT00417248
Status:
TERMINATED
Last Update Posted:
2016-07-25
First Post:
2006-12-28
Brief Title:
CisplatinEtoposideRadiotherapy Followed by Consolidation Sorafenib for Inoperable Stage III Non-Small Cell Lung Cancer
Sponsor:
Nasser Hanna MD
Organization:
Hoosier Cancer Research Network
Organization Data
Organization:
Hoosier Cancer Research Network
Class:
OTHER
Study ID:
HOG LUN06-107
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Nasser Hanna MD
Lead Sponsor Class:
OTHER
Responsible Party:
Nasser Hanna MD
Responsible Party Title:
Sponsor-Investigator
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Hoosier Cancer Research Network
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Bayer | INDUSTRY |
| Amgen | INDUSTRY |
| Walther Cancer Institute | OTHER |